Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/2006
05/17/2006EP0923941B1 Remedies for myeloma to be used together with nitrogen mustard antitumor agents
05/17/2006EP0807124B1 Monoclonal antibody against flt4 receptor tyrosine kinase and its use in diagnosis and therapy
05/17/2006EP0716610B1 Human bone morphogenetic proteins for use in neural regeneration
05/17/2006CN1774635A Anti-epileptogenic agents
05/17/2006CN1774450A Cross-linked polysaccharide composition
05/17/2006CN1774251A Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
05/17/2006CN1772751A Substituted oxazolidinones and their use in the field of blood coagulation
05/17/2006CN1772733A Cyanopyrrolidine derivatives
05/17/2006CN1772292A Nutrient for preventing sudden death
05/17/2006CN1772282A Chinese herbal medicine decoction for treating phlegm-wetness low fever and its prepn
05/17/2006CN1772270A Tiantan prepn for treating kidney-yang deficiency diseases and its production process
05/17/2006CN1772252A Making process of children's hyperkinesia treating capsule
05/17/2006CN1772245A Snake medicinal wine for health care massage and its application
05/17/2006CN1772227A Chinese medicine prepn with body balance essence and its prepn process
05/17/2006CN1772223A Chinese herbal medicine decoction for treating Yin deficiency night sweat and its prepn
05/17/2006CN1772222A Chinese herbal medicine decoction for treating Yang deficiency spontaneous perspiration and its prepn
05/17/2006CN1772218A Heatstroke treating medicine
05/17/2006CN1772181A Face nursing and life prolonging capsule and its prepn
05/17/2006CN1772180A Chinese herbal medicine decoction for treating Yin-deficiency low fever and its prepn
05/17/2006CN1772179A Chinese herbal medicine decoction for treating wetness type low fever and its prepn
05/17/2006CN1772176A Prepn process of granule for treating children's hyperkinesia and its quality control method
05/17/2006CN1772140A Chinese herbal medicine decoction for treating dyspepsia type low fever and its prepn
05/17/2006CN1772128A Recipe of medicine for massage to relax muscles and joints and to defoxicate
05/17/2006CN1772103A Chinese herbal medicine decoction for treating blood deficiency low fever and its prepn
05/17/2006CN1772066A New use of peach tree in killing bacteria, killing pest, detoxicating, treating disease and preserving health
05/17/2006CN1772038A Chinese Herbal medicine decoction for treating vital energy deficiency low fever and its prepn
05/17/2006CN1772036A Application of astragalus extract in preparing antifatigue medicine
05/17/2006CN1771997A Trachyostracous mussel extract and its prepn and use
05/17/2006CN1771943A Novel method of treatment
05/17/2006CN1771935A Cremaster ketone prepn
05/17/2006CN1771825A Chrysanthemum-bamboo tea
05/17/2006CN1256334C Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists
05/17/2006CN1256324C Pyrrolidine derivatives as factor Xa inhibitors
05/17/2006CN1256147C CD8 as inhibitor of cellular immune system
05/17/2006CN1256146C Aqueous formulations of LHRH related peptide compound and preparing method and use thereof
05/17/2006CN1256133C Antifatigue Chinese medicine composition and its preparation process
05/17/2006CN1256110C Chinese medicine for expelling stasis
05/17/2006CN1256108C Ass-hide glue phosphotipid composition and its preparing method
05/17/2006CN1256097C Yak-blood deproteined extract and its extraction method and use thereof
05/17/2006CN1256084C Applicaton of medicine for garlic oil anti radiation aleucocytosis reduction and DNA injury
05/16/2006US7045665 substituted benzylphenol derivatives as intermediates for glucopyranosyloxybenzylbenzene derivatives; agents for the prevention or treatment of diabetes, diabetic complications, obesity or the like
05/16/2006US7045661 Crystalline forms of venlafaxine hydrochloride
05/16/2006US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor
05/16/2006US7045658 prophylaxis and treatment of respiratory diseases; phenethanolamine derivatives
05/16/2006US7045636 MCH antagonists for the treatment of obesity
05/16/2006US7045631 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands
05/16/2006US7045626 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-CD23
05/16/2006US7045613 IKK-αproteins, nucleic acids and methods
05/16/2006US7045604 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
05/16/2006US7045596 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
05/16/2006US7045594 Serine proteinase inhibitors
05/16/2006US7045591 Cyclic peptide for use in the treatment of eating disorders
05/16/2006US7045540 Selective estrogen receptor modulators
05/16/2006US7045534 Methods of reducing angiogenesis
05/16/2006US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout
05/16/2006US7045528 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
05/16/2006US7045526 Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical preparations comprising them
05/16/2006US7045522 8-Azabicyclo[3.2.1]oct-2-ene and -octane derivatives technical field
05/16/2006US7045521 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents
05/16/2006US7045520 Opioid receptor active compounds
05/16/2006US7045514 Therapeutic heterocyclic compounds
05/16/2006US7045509 Proteins and nucleic acids encoding same
05/16/2006US7045507 Substituted tetracycline compounds as synergistic antifungal agents
05/16/2006US7045505 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders
05/16/2006US7045502 Administering concurrent with cell grafting surgery using insulin producing stem cells
05/16/2006US7045500 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive
05/16/2006US7045323 Glutathione reductase for therapy and prophylaxis of aids
05/16/2006US7045318 Recombinant fusion proteins to growth hormone and serum albumin
05/16/2006US7045315 Methods for modulating expression of exogenous genes in mammalian systems
05/16/2006US7045148 Recovering embryonic-like stem cells from a placenta; obtain placenta, drain cord blood, flush placenta with anticoagulant solution, recover cells
05/16/2006US7045146 Treating the solid particle material with an amphiphilic substance and coating the material with a layer of a charged polyelectrolyte or with a multilayer comprising alternating layers of oppositely charged polyelectrolytes.
05/16/2006US7045140 Therapeutic delivery of carbon monoxide
05/16/2006US7045118 Delivery of compounds for the treatment of migraine through an inhalation route
05/16/2006CA2366856C Formulation comprising testosteron undecanoate and castor oil
05/16/2006CA2237752C Novel substituted aryl compounds useful as modulators of acetylcholine receptors
05/16/2006CA2197628C Substituted thiophenylalkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
05/16/2006CA2192797C Indolinone compounds for the treatment of disease
05/16/2006CA2192535C 2-naphtamides derivatives and therapeutic uses thereof
05/11/2006WO2006050314A2 Once a day formulation for phosphate binders
05/11/2006WO2006050241A1 Prostaglandin ep4 antagonists
05/11/2006WO2006049339A1 Novel fused imidazole derivative
05/11/2006WO2006049336A1 Method of preparing stem cells and tissue remedy
05/11/2006WO2006049304A1 Aryloxy-substituted benzimidazole derivatives
05/11/2006WO2006049258A1 Polymeric polyphenol extracted from fermented tea, therapeutic agent for mitochondrial disease, preventive/therapeutic agent for diabetes mellitus, and food or beverage
05/11/2006WO2006049250A1 Aqueous eye drops with accelerated intraocular migration
05/11/2006WO2006049234A1 Peroxisome proliferator-activated receptor (ppar) activator and drug, supplement, functional food and food additive using the same
05/11/2006WO2006049215A1 Combination drug for treating autoimmune disease
05/11/2006WO2006049157A1 Multimeric oleamide derivative having connexin-26 inhibiting potency and use thereof in cancer therapy, etc.
05/11/2006WO2005034912A3 Ferromagnetic particles and methods
05/11/2006US20060101530 Rors as modifiers of the p21 pathway and methods of use
05/11/2006US20060100427 Alzheimer's disease and other diseases relating to amyloid deposits; neurodegenerative diseases
05/11/2006US20060100283 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
05/11/2006US20060100280 Cell growth regulator
05/11/2006US20060100261 Furan or thiopene derivative and medicinal use thereof
05/11/2006US20060100252 Beta 3 adrenergic receptor agonists; pollakiuria or urinary incontinence; antiulcer, overactive bladder, pancreatitis, obesity, diabetes, insulin resistance, hypertriglyceridemia, hypercholesterolemia, tocolytic agents; 4'-[2-(2-hydroxy-2-phenylethyl]amino]ethyl]-4-biphenylyl]acetic acid
05/11/2006US20060100249 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
05/11/2006US20060100247 Treatment of diabetes with thiazolidinedione and metformin
05/11/2006US20060100246 Synthesis of I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs, by reacting an aryl ketone, an aldehyde and a cyanoacetate with an ammonium salt
05/11/2006US20060100244 Such as (3-chloro-4-fluorophenyl)(4-fluoro-4-{[(5-hydoxypyridin-2-ylmethyl)amino]methyl}piperidin-1-yl)methanone; serotonin receptor agonists; for treating depression, pain, and substance abuse
05/11/2006US20060100241 Method for enhancing mutant protein activity